Cardiovascular Benefits of New Antidiabetic Drug Classes: A Network Meta-analysis

Cardiovascular Benefits of New Antidiabetic Drug Classes: A Network Meta-analysis

Saved in:

Bibliographic Details
Main Authors:	BMY Cheung, Y Fei, MF Tsoi
Format:	Article
Language:	English
Published:	Radcliffe Medical Media 2020-05-01
Series:	European Cardiology Review
Online Access:	https://www.ecrjournal.com/articleindex/ecr.2020.15.1.PO17
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Posters from the 24th Annual Scientific Meeting of the International Society of Cardiovascular Pharmacotherapy
by: BMY Cheung, et al.
Published: (2020-05-01)

Blood Lead Level and Hypertension Risk in the United States National Health Nutrition and Examination Survey (NHANES) 1999–2016
by: BMY Cheung, et al.
Published: (2020-05-01)

Comparative effectiveness of oral antidiabetic drugs in preventing cardiovascular mortality and morbidity: A network meta-analysis.
by: Gyeongsil Lee, et al.
Published: (2017-01-01)

Barriers in prescribing antidiabetic medications with cardiovascular benefits: practice, experience, and attitudes of GPs in Croatia
by: Tomislav Kurevija, et al.
Published: (2025-05-01)

Marketing analysis of the pharmaceutical market of antidiabetic drugs in Ukraine
by: A. O. Savych, et al.
Published: (2022-04-01)

Comparative efficacy and safety of antidiabetic drug regimens added to metformin monotherapy in patients with type 2 diabetes: a network meta-analysis.
by: Elizabeth S Mearns, et al.
Published: (2015-01-01)

Effects of Newer Antidiabetic Drugs on Endothelial Function and Arterial Stiffness: A Systematic Review and Meta-Analysis
by: Konstantinos Batzias, et al.
Published: (2018-01-01)

Mechanisms of cardiovascular protection of non-insulin antidiabetic medications
by: Angelo Avogaro
Published: (2018-11-01)

Prevalence of adherence to oral antidiabetic drugs in patients with type 2 diabetes: A systematic review and meta‐analysis
by: Kansak Boonpattharatthiti, et al.
Published: (2024-11-01)

Cardiovascular Effectiveness and Safety of Antidiabetic Drugs in Patients with Type 2 Diabetes and Peripheral Artery Disease: Systematic Review
by: Antonio Cimellaro, et al.
Published: (2024-09-01)

Molecular modeling approach in design of new scaffold of α-glucosidase inhibitor as antidiabetic drug
by: Fatemeh Amini, et al.
Published: (2025-06-01)

ANALYSIS OF ANTIDIABETIC DRUGS ASSORTMENT REPRESENTED ON THE PHARMACEUTICAL MARKET OF SAINT PETERSBURG
by: Yu. V. Miroshnichenko, et al.
Published: (2015-10-01)

Revolutionary drug repositioning: the preventive and therapeutic potential of metformin and other antidiabetic drugs in age-related macular degeneration
by: Yating Zhou, et al.
Published: (2024-12-01)

Antidiabetic drugs and the risk of cancer: beneficial, neutral, or detrimental?
by: Azeez Taoreed Adegoke, et al.
Published: (2021-08-01)

Health Benefits of Traditional Sage and Peppermint Juices: Simple Solutions for Antioxidant and Antidiabetic Support
by: Sanja Krstić, et al.
Published: (2025-03-01)

The applying of immunohistochemical method for evaluating the cytoprotective effect of antidiabetic drugs
by: S. V. Ivanov
Published: (2018-11-01)

Antidiabetic Drugs in Alzheimer’s Disease: Mechanisms of Action and Future Perspectives
by: Grazia Daniela Femminella, et al.
Published: (2017-01-01)

Dietary Sources and Amounts of Flavan-3-Ols for Cardiovascular Benefit – A Meta-Analysis
by: Julie Shlisky, et al.
Published: (2025-05-01)

Benefits of therapeutic drug monitoring of vancomycin: a systematic review and meta-analysis.
by: Zhi-Kang Ye, et al.
Published: (2013-01-01)

White adipose tissue in type 2 diabetes and the effect of antidiabetic drugs
by: Yixuan Zhao, et al.
Published: (2025-04-01)

Pharmacokinetics and drug-likeness of antidiabetic flavonoids: Molecular docking and DFT study.
by: Mamaru Bitew, et al.
Published: (2021-01-01)

Genetic Variation in Targets of Antidiabetic Drugs and Amyotrophic Lateral Sclerosis Risk
by: Mengxia Wan, et al.
Published: (2024-11-01)

Assessment of Patients’ Views on Drug Benefits and Risks: An Interview Study with Cardiovascular Patients
by: Ines Wakob, et al.
Published: (2022-01-01)

Comparative efficacy of once-weekly semaglutide versus SGLT-2 inhibitors in patients inadequately controlled with one to two oral antidiabetic drugs: a systematic literature review and network meta-analysis
by: Steve Kanters, et al.
Published: (2019-07-01)

Comparative efficacy of different antihypertensive drug classes for stroke prevention: A network meta-analysis of randomized controlled trials.
by: Ding Yu, et al.
Published: (2025-01-01)

Isolation and Determination of Fomentariol: Novel Potential Antidiabetic Drug from Fungal Material
by: Nevena Maljurić, et al.
Published: (2018-01-01)

Enhancing Antidiabetic Drug Selection Using Transformers: Machine-Learning Model Development
by: Hisashi Kurasawa, et al.
Published: (2025-06-01)

Adverse Drug Reaction Profiling of Antidiabetics, Antianginals and Antibiotics based on Hospital Survey
by: Sk Md Khalid, et al.
Published: (2022-09-01)

Landscape of pharmacogenetic variants associated with non-insulin antidiabetic drugs in the Indian population
by: Anura V Kurpad, et al.
Published: (2024-04-01)

Urban parks biowaste as a sustainable source of new antidiabetics
by: Marijan Marijan, et al.
Published: (2024-12-01)

Standardized Chromatographic and Computational Approaches for Lipophilicity Analysis of Five Gliflozin Antidiabetic Drugs in Relation to Their Biological Activity
by: Anna Gumieniczek, et al.
Published: (2024-12-01)

Incremental long-term benefit of drug therapies for chronic obstructive pulmonary disease in quality of life but not mortality: a network meta-analysis
by: Qiong Pan, et al.
Published: (2024-05-01)

Real-world evidence on the association of novel antidiabetic medication use with cancer risk and protective effects: a systematic review and network meta-analysis
by: Ahmed S. Kenawy, et al.
Published: (2025-04-01)

Impact of antihypertensive drug classes on cardiovascular outcomes: insights from the STEP study
by: Xinyi Peng, et al.
Published: (2025-07-01)

Risk of hepatocellular carcinoma in adults exposed to oral antidiabetic drugs: a systematic review
by: Shadman Newaz, et al.
Published: (2025-06-01)

Development and Validation of an HPLC Method for Determination of Antidiabetic Drug Alogliptin Benzoate in Bulk and Tablets
by: Hani Naseef, et al.
Published: (2018-01-01)

Metabolic imbalance and brain tumors: The interlinking metabolic pathways and therapeutic actions of antidiabetic drugs
by: Young-Kook Kim, et al.
Published: (2025-05-01)

The landscape of novel antidiabetic drugs in diabetic HFpEF: relevant mechanisms and clinical implications
by: Xiangling Duan, et al.
Published: (2025-04-01)

Protective effect of antidiabetic drugs against male infertility: evidence from Mendelian randomization
by: Yuqi Li, et al.
Published: (2025-04-01)

A Review of the Sustainability, Chemical Composition, Bioactive Compounds, Antioxidant and Antidiabetic Activity, Neuroprotective Properties, and Health Benefits of Microalgae
by: Maria Dimopoulou, et al.
Published: (2025-02-01)